{"symbol":"ABBV","fiscalQuarter":"Q1-2024","reportDate":"2024-04-26","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q1-2024","postBrief":{"headline":"AbbVie Misses on EPS, Stock Down 4.58%","keyNumbers":[{"metric":"EPS","actual":"$2.31","expected":"N/A","surprise":"-1.58%"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management noted ongoing challenges in the market.","They emphasized a focus on cost management and efficiency.","Future growth will depend on pipeline developments."],"summary":"Management expressed concerns about current market conditions impacting performance. They highlighted the importance of cost management while focusing on future growth opportunities."},"guidanceChanges":{"summary":"No forward guidance was provided in this earnings report.","changes":[]},"whatItMeans":"AbbVie's earnings report shows a slight miss on EPS, which contributed to a significant drop in stock price by 4.58%. The lack of revenue figures and forward guidance adds uncertainty for investors. Management's defensive tone suggests they are cautious about upcoming challenges, which could impact investor sentiment moving forward.","metaDescription":"AbbVie Inc (ABBV) Q1 2024 earnings: EPS missed expectations. Stock down 4.58%. Full breakdown."}}